S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7129 +0.28%
CLOSED · 02:35 ET
Market ClerkRecap
Thu Oct 22 · markets closed2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 30The week ahead

ACRS

Aclaris Therapeutics, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
3.81
+0.04 +1.06%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $560.8MP/E —DIV YIELD —FCF YIELD -11.09%REV TTM $8.2M −51.0%NET INCOME −$75.7MNET CASH $8.4M52W 2.13 – 6.53SEC XBRL · TTM TO Invalid Date

How ACRS rewrote its risk factors

10-K ITEM 1A · YEAR OVER YEAR
We haven’t read ACRS’s 10-K risk factors yet. The sweep covers about 40 companies a day across the fundamentals universe.
Watch ACRS. Know when insiders buy.
One email the day a filing lands. Free.